|
MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 03, 2018 12:42PM
|
|
Upcoming Dimentia news in early Dec
|
4
|
Resverlogix Corp.
|
Nov 05, 2019 01:27AM
|
|
Re: 4-8b guess - Is someone asking too much?
|
4
|
Resverlogix Corp.
|
Dec 09, 2019 07:51AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
4
|
Resverlogix Corp.
|
Dec 02, 2019 09:07AM
|
|
Re: 4-8b guess - Is someone asking too much?
|
4
|
Resverlogix Corp.
|
Dec 09, 2019 08:16AM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 01:31PM
|
|
Re: Short interest has been updated, can someone check the numbers....
|
4
|
Resverlogix Corp.
|
Jun 21, 2019 08:54AM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
4
|
Resverlogix Corp.
|
Dec 05, 2019 08:48PM
|
|
Saw these articles that might be relevant to us,...
|
4
|
Resverlogix Corp.
|
Sep 20, 2018 11:26AM
|
|
Number of Patient Years
|
4
|
Resverlogix Corp.
|
Apr 11, 2019 10:38AM
|
|
Statistical Significance
|
4
|
Resverlogix Corp.
|
Apr 13, 2019 07:50AM
|
|
Re: Volume almost 100,000 at 11am
|
4
|
Resverlogix Corp.
|
Mar 13, 2019 11:08AM
|
|
Interesting Dementia article
|
4
|
Resverlogix Corp.
|
Oct 09, 2019 09:41AM
|
|
Re: What if BETonMACE had more CKD patients?
|
4
|
Resverlogix Corp.
|
Dec 27, 2019 08:57AM
|
|
Re: Message from Sarah this early afternoon regarding the warrants
|
5
|
Resverlogix Corp.
|
Jan 10, 2020 03:02PM
|
|
Re: And there's the news, 3 month loan extension....
|
5
|
Resverlogix Corp.
|
May 04, 2019 02:47PM
|
|
Can we expect for 5 point MACE to be near our phase 2 trials results
|
5
|
Resverlogix Corp.
|
Apr 02, 2019 11:27AM
|
|
Re: BTD Values
|
5
|
Resverlogix Corp.
|
Feb 17, 2020 05:21AM
|
|
Re: Naz listing?
|
5
|
Resverlogix Corp.
|
Apr 20, 2019 08:27AM
|
|
Re: In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 08:54AM
|
